AirSeal®Insufflation Trocar/CO2 Absorption Study

Sponsor
Columbia University (Other)
Overall Status
Completed
CT.gov ID
NCT02654808
Collaborator
SurgiQuest, Inc. (Industry)
132
1
4
12
11

Study Details

Study Description

Brief Summary

The purpose of this study is to compare carbon dioxide (CO2) absorption during gynecologic laparoscopy using the AirSeal® valveless trocar system versus standard insufflation trocars at intra-abdominal pressures of 10 and 15 mmHg.

The investigators hypothesize that with the AirSeal® valveless trocar system, gynecologic laparoscopy can be performed at a lower intra-abdominal pressure with a possible resultant decrease in CO2 absorption, while maintaining adequate visualization of the operative field for safe completion of surgery.

Condition or Disease Intervention/Treatment Phase
  • Device: AirSeal trocar
  • Device: Standard trocar
N/A

Detailed Description

Three main factors affect patients' cardiopulmonary status during gynecologic laparoscopy: 1) degree of Trendelenburg tilt (25 - 30°), 2) carbon dioxide (CO2) absorption and 3) increased intra-abdominal pressure (10 -20 mmHg). Slight modifications to any or all of these three factors can lead to a significant decrease in morbidity.

The AirSeal® valveless trocar system reduces CO2 absorption when compared to standard trocars during renal laparoscopy. Also, use of this trocar system provides a more stable intra-abdominal pressure when compared to standard trocars, a feature that could possibly allow for laparoscopic surgery to be performed at lower intra-abdominal pressures.

Study Design

Study Type:
Interventional
Actual Enrollment :
132 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Other
Official Title:
A Comparison of CO2 Absorption During Gynecologic Laparoscopy Using the AirSeal® Valveless Trocar System Versus Standard Insufflation Trocars at Intra-abdominal Pressures of 10 mmHg and 15 mmHg - a Randomized Controlled Trial
Actual Study Start Date :
May 1, 2016
Actual Primary Completion Date :
Apr 1, 2017
Actual Study Completion Date :
May 1, 2017

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Standard trocar/ IAP 15 mmHg

Patients who are randomized into this arm will have their laparoscopic procedures performed with the standard trocar insufflator at an intra-abdominal pressure (IAP) of 15 mmHg.

Device: Standard trocar
A standard insufflation trocar delivers CO2 into the abdominal cavity to create workspace and uses either a "trap door" or silicone valve to prevent the egress of CO2 during laparoscopy in order to maintain intra-abdominal pressures. The standard trocars are not equipped to respond to changes in the intra-abdominal pressures in order to trigger an increase or decrease in the flow rate of CO2 gas.

Active Comparator: Standard trocar/ IAP 10 mmHg

Patients who are randomized into this arm will have their laparoscopic procedures performed with the standard trocar insufflator at an intra-abdominal pressure (IAP) of 10 mmHg.

Device: Standard trocar
A standard insufflation trocar delivers CO2 into the abdominal cavity to create workspace and uses either a "trap door" or silicone valve to prevent the egress of CO2 during laparoscopy in order to maintain intra-abdominal pressures. The standard trocars are not equipped to respond to changes in the intra-abdominal pressures in order to trigger an increase or decrease in the flow rate of CO2 gas.

Active Comparator: AirSeal trocar/ IAP 15 mmHg

Patients who are randomized into this arm will have their laparoscopic procedures performed with the AirSeal trocar insufflator at an intra-abdominal pressure (IAP) of 15 mmHg.

Device: AirSeal trocar
The AirSeal® trocar is a valveless trocar that has been designed to replace the "trap door" and silicone valve of standard trocars with a curtain of forced CO2 gas. With the AirSeal® trocar, escaping gas is collected at the proximal end of the trocar, filtered, and redirected into the peritoneal cavity to maintain the pressure differential. The result is an invisible barrier that instantaneously responds to changes in intra-abdominal pressure, either by allowing more CO2 inflow with pressure drops or by serving as a pressure relief valve during pressure spikes.

Active Comparator: AirSeal trocar/ IAP 10 mmHg

Patients who are randomized into this arm will have their laparoscopic procedures performed with the AirSeal trocar insufflator at an intra-abdominal pressure (IAP) of 10 mmHg.

Device: AirSeal trocar
The AirSeal® trocar is a valveless trocar that has been designed to replace the "trap door" and silicone valve of standard trocars with a curtain of forced CO2 gas. With the AirSeal® trocar, escaping gas is collected at the proximal end of the trocar, filtered, and redirected into the peritoneal cavity to maintain the pressure differential. The result is an invisible barrier that instantaneously responds to changes in intra-abdominal pressure, either by allowing more CO2 inflow with pressure drops or by serving as a pressure relief valve during pressure spikes.

Outcome Measures

Primary Outcome Measures

  1. Average Carbon Dioxide (CO2) Absorption During Gynecologic Laparoscopy Using the AirSeal® Versus Standard Trocars at Intra-abdominal Pressures of 10 mmHg [15 minutes & 60 minutes from surgery start time]

    This outcome is measured by calculating the CO2 elimination rate. CO2 absorption rates were obtained at 15 and 60 minutes during each case and an average value was calculated per case. In cases < 60 minutes, the CO2 absorption rate at 15 minutes will be used.

Secondary Outcome Measures

  1. Median Surgeon Questionnaire Score When Using AirSeal® Versus Standard Trocars [At the end of surgery (approximately 1 hour)]

    Surgeon Questionnaire (0 "not adequate" -10 "optimal") is designed to evaluate the visualization of operative field by surgeon during colpotomy.

  2. Number of Participants With no Problem When Using AirSeal® Versus Standard Trocars [At the end of surgery (approximately 1 hour)]

    Anesthesia Questionnaire (0 "no problem" - 2 "very problematic) is designed to evaluate the the level of difficulty in maintaining adequate end-tidal CO2 (etCO2).

  3. Median VAS Pain Score When Using AirSeal® Versus Standard Trocars [4 to 6 hours, and 12 to 23 hours following surgery]

    Visual Analog Scale (VAS) Pain Score (0 "no pain" - 10 "worst pain") is designed to evaluate the level of pain post-surgery.

  4. Average Carbon Dioxide (CO2) Absorption During Gynecologic Laparoscopy Using the AirSeal® Versus Standard Trocars at Intra-abdominal Pressures of 15 mmHg [15 minutes & 60 minutes from surgery start time]

    This outcome is measured by calculating the CO2 elimination rate.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Any woman ≥ 18 years of age undergoing a gynecologic laparoscopic procedure

  • Able to understand the consenting process and willing to participate in study

Exclusion Criteria:
  • Patient unable to undergo laparoscopic procedure due to size of pathology or medical comorbidities

  • Emergent surgery

Contacts and Locations

Locations

Site City State Country Postal Code
1 Columbia University Medical Center New York New York United States 10032

Sponsors and Collaborators

  • Columbia University
  • SurgiQuest, Inc.

Investigators

  • Principal Investigator: Timothy Ryntz, MD, Columbia University

Study Documents (Full-Text)

More Information

Publications

Responsible Party:
Columbia University
ClinicalTrials.gov Identifier:
NCT02654808
Other Study ID Numbers:
  • AAAQ6474
First Posted:
Jan 13, 2016
Last Update Posted:
Sep 16, 2021
Last Verified:
Aug 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
Yes
Product Manufactured in and Exported from the U.S.:
No
Keywords provided by Columbia University

Study Results

Participant Flow

Recruitment Details
Pre-assignment Detail
Arm/Group Title Standard Trocar/ IAP 15 mmHg Standard Trocar/ IAP 10 mmHg AirSeal Trocar/ IAP 15 mmHg AirSeal Trocar/ IAP 10 mmHg
Arm/Group Description Patients who are randomized into this arm will have their laparoscopic procedures performed with the standard trocar insufflator at an intra-abdominal pressure (IAP) of 15 mmHg. Standard trocar: A standard insufflation trocar delivers CO2 into the abdominal cavity to create workspace and uses either a "trap door" or silicone valve to prevent the egress of CO2 during laparoscopy in order to maintain intra-abdominal pressures. The standard trocars are not equipped to respond to changes in the intra-abdominal pressures in order to trigger an increase or decrease in the flow rate of CO2 gas. Patients who are randomized into this arm will have their laparoscopic procedures performed with the standard trocar insufflator at an intra-abdominal pressure (IAP) of 10 mmHg. Standard trocar: A standard insufflation trocar delivers CO2 into the abdominal cavity to create workspace and uses either a "trap door" or silicone valve to prevent the egress of CO2 during laparoscopy in order to maintain intra-abdominal pressures. The standard trocars are not equipped to respond to changes in the intra-abdominal pressures in order to trigger an increase or decrease in the flow rate of CO2 gas. Patients who are randomized into this arm will have their laparoscopic procedures performed with the AirSeal trocar insufflator at an intra-abdominal pressure (IAP) of 15 mmHg. AirSeal trocar: The AirSeal® trocar is a valveless trocar that has been designed to replace the "trap door" and silicone valve of standard trocars with a curtain of forced CO2 gas. With the AirSeal® trocar, escaping gas is collected at the proximal end of the trocar, filtered, and redirected into the peritoneal cavity to maintain the pressure differential. The result is an invisible barrier that instantaneously responds to changes in intra-abdominal pressure, either by allowing more CO2 inflow with pressure drops or by serving as a pressure relief valve during pressure spikes. Patients who are randomized into this arm will have their laparoscopic procedures performed with the AirSeal trocar insufflator at an intra-abdominal pressure (IAP) of 10 mmHg. AirSeal trocar: The AirSeal® trocar is a valveless trocar that has been designed to replace the "trap door" and silicone valve of standard trocars with a curtain of forced CO2 gas. With the AirSeal® trocar, escaping gas is collected at the proximal end of the trocar, filtered, and redirected into the peritoneal cavity to maintain the pressure differential. The result is an invisible barrier that instantaneously responds to changes in intra-abdominal pressure, either by allowing more CO2 inflow with pressure drops or by serving as a pressure relief valve during pressure spikes.
Period Title: Overall Study
STARTED 33 33 33 33
COMPLETED 33 33 33 33
NOT COMPLETED 0 0 0 0

Baseline Characteristics

Arm/Group Title Standard Trocar/ IAP 15 mmHg Standard Trocar/ IAP 10 mmHg AirSeal Trocar/ IAP 15 mmHg AirSeal Trocar/ IAP 10 mmHg Total
Arm/Group Description Patients who are randomized into this arm will have their laparoscopic procedures performed with the standard trocar insufflator at an intra-abdominal pressure (IAP) of 15 mmHg. Standard trocar: A standard insufflation trocar delivers CO2 into the abdominal cavity to create workspace and uses either a "trap door" or silicone valve to prevent the egress of CO2 during laparoscopy in order to maintain intra-abdominal pressures. The standard trocars are not equipped to respond to changes in the intra-abdominal pressures in order to trigger an increase or decrease in the flow rate of CO2 gas. Patients who are randomized into this arm will have their laparoscopic procedures performed with the standard trocar insufflator at an intra-abdominal pressure (IAP) of 10 mmHg. Standard trocar: A standard insufflation trocar delivers CO2 into the abdominal cavity to create workspace and uses either a "trap door" or silicone valve to prevent the egress of CO2 during laparoscopy in order to maintain intra-abdominal pressures. The standard trocars are not equipped to respond to changes in the intra-abdominal pressures in order to trigger an increase or decrease in the flow rate of CO2 gas. Patients who are randomized into this arm will have their laparoscopic procedures performed with the AirSeal trocar insufflator at an intra-abdominal pressure (IAP) of 15 mmHg. AirSeal trocar: The AirSeal® trocar is a valveless trocar that has been designed to replace the "trap door" and silicone valve of standard trocars with a curtain of forced CO2 gas. With the AirSeal® trocar, escaping gas is collected at the proximal end of the trocar, filtered, and redirected into the peritoneal cavity to maintain the pressure differential. The result is an invisible barrier that instantaneously responds to changes in intra-abdominal pressure, either by allowing more CO2 inflow with pressure drops or by serving as a pressure relief valve during pressure spikes. Patients who are randomized into this arm will have their laparoscopic procedures performed with the AirSeal trocar insufflator at an intra-abdominal pressure (IAP) of 10 mmHg. AirSeal trocar: The AirSeal® trocar is a valveless trocar that has been designed to replace the "trap door" and silicone valve of standard trocars with a curtain of forced CO2 gas. With the AirSeal® trocar, escaping gas is collected at the proximal end of the trocar, filtered, and redirected into the peritoneal cavity to maintain the pressure differential. The result is an invisible barrier that instantaneously responds to changes in intra-abdominal pressure, either by allowing more CO2 inflow with pressure drops or by serving as a pressure relief valve during pressure spikes. Total of all reporting groups
Overall Participants 33 33 33 33 132
Age (Count of Participants)
<=18 years
0
0%
0
0%
0
0%
0
0%
0
0%
Between 18 and 65 years
33
100%
33
100%
33
100%
33
100%
132
100%
>=65 years
0
0%
0
0%
0
0%
0
0%
0
0%
Sex: Female, Male (Count of Participants)
Female
33
100%
33
100%
33
100%
33
100%
132
100%
Male
0
0%
0
0%
0
0%
0
0%
0
0%
Race (NIH/OMB) (Count of Participants)
American Indian or Alaska Native
0
0%
0
0%
0
0%
0
0%
0
0%
Asian
3
9.1%
1
3%
9
27.3%
5
15.2%
18
13.6%
Native Hawaiian or Other Pacific Islander
0
0%
0
0%
0
0%
1
3%
1
0.8%
Black or African American
9
27.3%
13
39.4%
8
24.2%
4
12.1%
34
25.8%
White
14
42.4%
12
36.4%
6
18.2%
17
51.5%
49
37.1%
More than one race
0
0%
0
0%
0
0%
0
0%
0
0%
Unknown or Not Reported
7
21.2%
7
21.2%
10
30.3%
6
18.2%
30
22.7%

Outcome Measures

1. Primary Outcome
Title Average Carbon Dioxide (CO2) Absorption During Gynecologic Laparoscopy Using the AirSeal® Versus Standard Trocars at Intra-abdominal Pressures of 10 mmHg
Description This outcome is measured by calculating the CO2 elimination rate. CO2 absorption rates were obtained at 15 and 60 minutes during each case and an average value was calculated per case. In cases < 60 minutes, the CO2 absorption rate at 15 minutes will be used.
Time Frame 15 minutes & 60 minutes from surgery start time

Outcome Measure Data

Analysis Population Description
132 patients were enrolled and randomized into 1 of 4 study arms: standard insufflation/IAP 10 (S/10), standard insufflation/IAP 15 (S/15), valveless insufflation/IAP 10 (V/10), valveless insufflation/IAP 15 (V/15).
Arm/Group Title Standard Trocar/ IAP 15 mmHg Standard Trocar/ IAP 10 mmHg AirSeal Trocar/ IAP 15 mmHg AirSeal Trocar/ IAP 10 mmHg
Arm/Group Description Patients who are randomized into this arm will have their laparoscopic procedures performed with the standard trocar insufflator at an intra-abdominal pressure (IAP) of 15 mmHg. Standard trocar: A standard insufflation trocar delivers CO2 into the abdominal cavity to create workspace and uses either a "trap door" or silicone valve to prevent the egress of CO2 during laparoscopy in order to maintain intra-abdominal pressures. The standard trocars are not equipped to respond to changes in the intra-abdominal pressures in order to trigger an increase or decrease in the flow rate of CO2 gas. Patients who are randomized into this arm will have their laparoscopic procedures performed with the standard trocar insufflator at an intra-abdominal pressure (IAP) of 10 mmHg. Standard trocar: A standard insufflation trocar delivers CO2 into the abdominal cavity to create workspace and uses either a "trap door" or silicone valve to prevent the egress of CO2 during laparoscopy in order to maintain intra-abdominal pressures. The standard trocars are not equipped to respond to changes in the intra-abdominal pressures in order to trigger an increase or decrease in the flow rate of CO2 gas. Patients who are randomized into this arm will have their laparoscopic procedures performed with the AirSeal trocar insufflator at an intra-abdominal pressure (IAP) of 15 mmHg. AirSeal trocar: The AirSeal® trocar is a valveless trocar that has been designed to replace the "trap door" and silicone valve of standard trocars with a curtain of forced CO2 gas. With the AirSeal® trocar, escaping gas is collected at the proximal end of the trocar, filtered, and redirected into the peritoneal cavity to maintain the pressure differential. The result is an invisible barrier that instantaneously responds to changes in intra-abdominal pressure, either by allowing more CO2 inflow with pressure drops or by serving as a pressure relief valve during pressure spikes. Patients who are randomized into this arm will have their laparoscopic procedures performed with the AirSeal trocar insufflator at an intra-abdominal pressure (IAP) of 10 mmHg. AirSeal trocar: The AirSeal® trocar is a valveless trocar that has been designed to replace the "trap door" and silicone valve of standard trocars with a curtain of forced CO2 gas. With the AirSeal® trocar, escaping gas is collected at the proximal end of the trocar, filtered, and redirected into the peritoneal cavity to maintain the pressure differential. The result is an invisible barrier that instantaneously responds to changes in intra-abdominal pressure, either by allowing more CO2 inflow with pressure drops or by serving as a pressure relief valve during pressure spikes.
Measure Participants 31 32 32 33
Mean (Standard Deviation) [mL/(kg*min)]
3.96
(1.19)
4.05
(1.08)
4.04
(1.54)
3.97
(1.00)
2. Secondary Outcome
Title Median Surgeon Questionnaire Score When Using AirSeal® Versus Standard Trocars
Description Surgeon Questionnaire (0 "not adequate" -10 "optimal") is designed to evaluate the visualization of operative field by surgeon during colpotomy.
Time Frame At the end of surgery (approximately 1 hour)

Outcome Measure Data

Analysis Population Description
132 patients were enrolled and randomized with 33 patients per arm. The participants were women ≥ 18 years old undergoing non-emergent conventional or robotic gynecologic laparoscopic surgery.
Arm/Group Title Standard 10 Standard 15 Valveless 10 Valveless 15
Arm/Group Description Standard insufflation system 10mmHg standard insufflation system 15 mmHg Valveless insufflation system 10 mmHg Valveless insufflation system 15 mmHg
Measure Participants 32 31 33 32
Baseline
10.0
(2.0)
10.0
(1.0)
10.0
(1.0)
10.0
(0.8)
At 15 minutes
8.0
(3.0)
8.0
(4.0)
10.0
(2.0)
10.0
(2.0)
At 30 minutes
8.0
(3.0)
8.0
(3.0)
9.0
(3.0)
9.0
(2.0)
Colpotomy
4.5
(4.0)
5.0
(4.0)
8.0
(4.0)
9.0
(2.0)
Overall
7.0
(3.0)
7.0
(2.0)
9.0
(2.0)
9.5
(1.8)
3. Secondary Outcome
Title Number of Participants With no Problem When Using AirSeal® Versus Standard Trocars
Description Anesthesia Questionnaire (0 "no problem" - 2 "very problematic) is designed to evaluate the the level of difficulty in maintaining adequate end-tidal CO2 (etCO2).
Time Frame At the end of surgery (approximately 1 hour)

Outcome Measure Data

Analysis Population Description
Women ≥ 18 years old undergoing non-emergent conventional or robotic gynecologic laparoscopic surgery.
Arm/Group Title Standard 10 Standard 15 Valveless 10 Valveless 15
Arm/Group Description Standard insufflation system 10mmHg standard insufflation system 15 mmHg Valveless insufflation system 10 mmHg Valveless insufflation system 15 mmHg
Measure Participants 32 31 33 32
Count of Participants [Participants]
30
90.9%
30
90.9%
32
97%
32
97%
4. Secondary Outcome
Title Median VAS Pain Score When Using AirSeal® Versus Standard Trocars
Description Visual Analog Scale (VAS) Pain Score (0 "no pain" - 10 "worst pain") is designed to evaluate the level of pain post-surgery.
Time Frame 4 to 6 hours, and 12 to 23 hours following surgery

Outcome Measure Data

Analysis Population Description
Post-operative shoulder pain of women ≥ 18 years old undergoing non-emergent conventional or robotic gynecologic laparoscopic surgery.
Arm/Group Title Standard 10 Standard 15 Valveless 10 Valveless 15
Arm/Group Description Standard insufflation system 10mmHg standard insufflation system 15 mmHg Valveless insufflation system 10 mmHg Valveless insufflation system 15 mmHg
Measure Participants 32 31 33 32
PACU arrival
0
(0)
0
(0)
0
(0)
0
(0)
PACU discharge
0
(2)
0
(0)
0
(4)
0
(1)
Post-operative Day #1
0
(4)
0
(4)
0
(4)
0
(5)
4 to 6 hours
0
(5)
0
(0)
0
(0)
0
(9)
12 to 23 hours
0
(0)
0
(0)
0
(2)
1.5
(7)
5. Secondary Outcome
Title Average Carbon Dioxide (CO2) Absorption During Gynecologic Laparoscopy Using the AirSeal® Versus Standard Trocars at Intra-abdominal Pressures of 15 mmHg
Description This outcome is measured by calculating the CO2 elimination rate.
Time Frame 15 minutes & 60 minutes from surgery start time

Outcome Measure Data

Analysis Population Description
Women ≥ 18 years old undergoing non-emergent conventional or robotic gynecologic laparoscopic surgery.
Arm/Group Title Standard 10 Standard 15 Valveless 10 Valveless 15
Arm/Group Description Standard insufflation system 10mmHg standard insufflation system 15 mmHg Valveless insufflation system 10 mmHg Valveless insufflation system 15 mmHg
Measure Participants 32 31 33 32
Mean (Standard Deviation) [mL/(kg*min)]
4.05
(1.08)
3.96
(1.19)
3.97
(1.00)
4.04
(1.54)

Adverse Events

Time Frame Up to 1 day following surgery
Adverse Event Reporting Description
Arm/Group Title Standard Trocar/ IAP 15 mmHg Standard Trocar/ IAP 10 mmHg AirSeal Trocar/ IAP 15 mmHg AirSeal Trocar/ IAP 10 mmHg
Arm/Group Description Patients who are randomized into this arm will have their laparoscopic procedures performed with the standard trocar insufflator at an intra-abdominal pressure (IAP) of 15 mmHg. Standard trocar: A standard insufflation trocar delivers CO2 into the abdominal cavity to create workspace and uses either a "trap door" or silicone valve to prevent the egress of CO2 during laparoscopy in order to maintain intra-abdominal pressures. The standard trocars are not equipped to respond to changes in the intra-abdominal pressures in order to trigger an increase or decrease in the flow rate of CO2 gas. Patients who are randomized into this arm will have their laparoscopic procedures performed with the standard trocar insufflator at an intra-abdominal pressure (IAP) of 10 mmHg. Standard trocar: A standard insufflation trocar delivers CO2 into the abdominal cavity to create workspace and uses either a "trap door" or silicone valve to prevent the egress of CO2 during laparoscopy in order to maintain intra-abdominal pressures. The standard trocars are not equipped to respond to changes in the intra-abdominal pressures in order to trigger an increase or decrease in the flow rate of CO2 gas. Patients who are randomized into this arm will have their laparoscopic procedures performed with the AirSeal trocar insufflator at an intra-abdominal pressure (IAP) of 15 mmHg. AirSeal trocar: The AirSeal® trocar is a valveless trocar that has been designed to replace the "trap door" and silicone valve of standard trocars with a curtain of forced CO2 gas. With the AirSeal® trocar, escaping gas is collected at the proximal end of the trocar, filtered, and redirected into the peritoneal cavity to maintain the pressure differential. The result is an invisible barrier that instantaneously responds to changes in intra-abdominal pressure, either by allowing more CO2 inflow with pressure drops or by serving as a pressure relief valve during pressure spikes. Patients who are randomized into this arm will have their laparoscopic procedures performed with the AirSeal trocar insufflator at an intra-abdominal pressure (IAP) of 10 mmHg. AirSeal trocar: The AirSeal® trocar is a valveless trocar that has been designed to replace the "trap door" and silicone valve of standard trocars with a curtain of forced CO2 gas. With the AirSeal® trocar, escaping gas is collected at the proximal end of the trocar, filtered, and redirected into the peritoneal cavity to maintain the pressure differential. The result is an invisible barrier that instantaneously responds to changes in intra-abdominal pressure, either by allowing more CO2 inflow with pressure drops or by serving as a pressure relief valve during pressure spikes.
All Cause Mortality
Standard Trocar/ IAP 15 mmHg Standard Trocar/ IAP 10 mmHg AirSeal Trocar/ IAP 15 mmHg AirSeal Trocar/ IAP 10 mmHg
Affected / at Risk (%) # Events Affected / at Risk (%) # Events Affected / at Risk (%) # Events Affected / at Risk (%) # Events
Total 0/33 (0%) 0/33 (0%) 0/33 (0%) 0/33 (0%)
Serious Adverse Events
Standard Trocar/ IAP 15 mmHg Standard Trocar/ IAP 10 mmHg AirSeal Trocar/ IAP 15 mmHg AirSeal Trocar/ IAP 10 mmHg
Affected / at Risk (%) # Events Affected / at Risk (%) # Events Affected / at Risk (%) # Events Affected / at Risk (%) # Events
Total 0/33 (0%) 0/33 (0%) 0/33 (0%) 0/33 (0%)
Other (Not Including Serious) Adverse Events
Standard Trocar/ IAP 15 mmHg Standard Trocar/ IAP 10 mmHg AirSeal Trocar/ IAP 15 mmHg AirSeal Trocar/ IAP 10 mmHg
Affected / at Risk (%) # Events Affected / at Risk (%) # Events Affected / at Risk (%) # Events Affected / at Risk (%) # Events
Total 0/33 (0%) 0/33 (0%) 0/33 (0%) 0/33 (0%)

Limitations/Caveats

[Not Specified]

More Information

Certain Agreements

All Principal Investigators ARE employed by the organization sponsoring the study.

There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.

Results Point of Contact

Name/Title Dr. Timothy Ryntz
Organization Columbia University
Phone 212-305-4973
Email ter2111@cumc.columbia.edu
Responsible Party:
Columbia University
ClinicalTrials.gov Identifier:
NCT02654808
Other Study ID Numbers:
  • AAAQ6474
First Posted:
Jan 13, 2016
Last Update Posted:
Sep 16, 2021
Last Verified:
Aug 1, 2021